意想不到的药物相互作用：GLP-1药物与镇静药物作用时间
1 分•作者: haebom•7 个月前
我最近开始使用替尔泊肽（Mounjaro）来管理体重，我注意到了一些意想不到的事情，我想知道其他人是否也有类似的经历，或者是否有相关的研究。背景：我之前因为严重的失眠，在另一位医生的处方下服用了唑吡坦和苯二氮卓类药物。开始使用Mounjaro后，我注意到镇静作用持续的时间比以前明显更长——出现长时间的脑雾和困倦，一直持续到第二天。这两位开药的医生都没有警告过我这种情况，这让我开始思考其中的机制。据我所知，GLP-1受体激动剂会导致胃排空延迟，理论上这可能会影响药物的吸收和代谢。但我经历的变化程度似乎很大。
我想向大家请教几个问题：
1. 是否有已发表的研究表明，GLP-1药物会影响其他药物的药代动力学，特别是中枢神经系统抑制剂？
2. 在使用司美格鲁肽、替尔泊肽或其他GLP-1激动剂期间，是否有其他人经历过类似的药物相互作用？
3. 如果GLP-1药物可以减缓镇静剂的吸收，那么同样的机制是否也会影响——甚至增强——像ADHD药物或咖啡因这样的兴奋剂的效果？我很好奇这是否会对专注力和生产力产生影响。
我分享这些是因为这些药物变得非常流行，如果存在未被广泛讨论的显著的药物相互作用，这似乎是一个重要的安全考虑因素。我特别担心的是，看多个专科医生的患者可能无法充分监督潜在的相互作用。
查看原文
I recently started tirzepatide (Mounjaro) for weight management, and I've noticed something unexpected that I'm curious if others have experienced or if there's research on this. Background: I've been prescribed zolpidem and benzodiazepines for severe insomnia by a different physician. After starting Mounjaro, I noticed the sedative effects lasting significantly longer than before - experiencing prolonged brain fog and grogginess that extends well into the next day. This wasn't something either prescribing physician warned me about, and it got me wondering about the mechanism. My understanding is that GLP-1 receptor agonists cause delayed gastric emptying, which could theoretically affect drug absorption and metabolism. But the degree of change I experienced seems substantial.<p>A few questions for the community:<p>1. Is there published research on GLP-1 medications affecting the pharmacokinetics of other drugs, particularly CNS depressants?<p>2. Has anyone else experienced similar interactions with medications while on semaglutide, tirzepatide, or other GLP-1 agonists?<p>3. If GLP-1 medications can slow the absorption of sedatives, could the same mechanism also influence — or even enhance — the effects of stimulants like ADHD meds or caffeine? I’m curious whether this could have implications for focus and productivity.<p>I'm sharing this because these medications are becoming extremely popular, and if there are significant drug interactions that aren't being routinely discussed, that seems like an important safety consideration. I'm particularly concerned that patients seeing multiple specialists might not have adequate oversight of potential interactions.